JP2011126791A - アレルギー疾患感受性遺伝子発現抑制物質 - Google Patents

アレルギー疾患感受性遺伝子発現抑制物質 Download PDF

Info

Publication number
JP2011126791A
JP2011126791A JP2009284069A JP2009284069A JP2011126791A JP 2011126791 A JP2011126791 A JP 2011126791A JP 2009284069 A JP2009284069 A JP 2009284069A JP 2009284069 A JP2009284069 A JP 2009284069A JP 2011126791 A JP2011126791 A JP 2011126791A
Authority
JP
Japan
Prior art keywords
gene expression
group
allergic disease
disease susceptibility
susceptibility gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009284069A
Other languages
English (en)
Japanese (ja)
Inventor
Hiroyuki Fukui
裕行 福井
Hiroyuki Mizuguchi
博之 水口
Yoshihisa Takaishi
喜久 高石
Yoshiki Kashiwada
良樹 柏田
Hisao Nemoto
尚夫 根本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokushima NUC
Original Assignee
University of Tokushima NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokushima NUC filed Critical University of Tokushima NUC
Priority to JP2009284069A priority Critical patent/JP2011126791A/ja
Priority to PCT/KR2010/008995 priority patent/WO2011074881A2/fr
Publication of JP2011126791A publication Critical patent/JP2011126791A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2009284069A 2009-12-15 2009-12-15 アレルギー疾患感受性遺伝子発現抑制物質 Withdrawn JP2011126791A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009284069A JP2011126791A (ja) 2009-12-15 2009-12-15 アレルギー疾患感受性遺伝子発現抑制物質
PCT/KR2010/008995 WO2011074881A2 (fr) 2009-12-15 2010-12-15 Substances destinées à inhiber l'expression de gènes pour la sensibilité à des troubles allergiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009284069A JP2011126791A (ja) 2009-12-15 2009-12-15 アレルギー疾患感受性遺伝子発現抑制物質

Publications (1)

Publication Number Publication Date
JP2011126791A true JP2011126791A (ja) 2011-06-30

Family

ID=44167871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009284069A Withdrawn JP2011126791A (ja) 2009-12-15 2009-12-15 アレルギー疾患感受性遺伝子発現抑制物質

Country Status (2)

Country Link
JP (1) JP2011126791A (fr)
WO (1) WO2011074881A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240158856A1 (en) * 2021-08-04 2024-05-16 Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd Primer probe set for human histamine receptor hrh1 mrna detection, kit and detection method
CN113604557A (zh) * 2021-08-04 2021-11-05 杭州浙大迪迅生物基因工程有限公司 一种人组胺受体HRH1 mRNA检测引物探针组、试剂盒和应用

Also Published As

Publication number Publication date
WO2011074881A2 (fr) 2011-06-23
WO2011074881A3 (fr) 2011-11-17

Similar Documents

Publication Publication Date Title
JP4810043B2 (ja) 細胞分裂阻害剤及びその製造方法
WO2017162108A1 (fr) Complexe de pillararène, son procédé de préparation, composition pharmaceutique et utilisation correspondantes
JPH01186893A (ja) 水溶性カンプトテシン類似体
KR20150081422A (ko) mTOR 경로 관련 질병 치료를 위한 화합물
KR101670590B1 (ko) Ｅｒｋ 신호활성 억제제를 유효성분으로 함유하는 암 줄기세포 성장 억제용 조성물
KR20140102599A (ko) 뇌암 치료를 위한 방법 및 조성물
JP2005029571A (ja) ＤＮＡ合成酵素λ阻害作用を有する化合物とその利用
JP5140231B2 (ja) ＩκＢキナーゼ阻害剤
JP6249415B2 (ja) 新規光線過敏症抑制剤トレハンジェリン物質及びその製造法
CN106456594A (zh) PPARγ活化剂
WO2013113294A1 (fr) Dérivé de stérol, son procédé de préparation et son utilisation
JPH1067656A (ja) 細胞接着抑制剤
JP2011126791A (ja) アレルギー疾患感受性遺伝子発現抑制物質
JP2018501304A (ja) シナラ・スコリムスの滴定抽出物及びそれらの使用
JP2010195831A (ja) ＩκＢキナーゼ阻害剤
JP5478082B2 (ja) インターロイキン−２産生抑制剤
CN113214097B (zh) 治疗阿尔茨海默病的化合物
CN112979541B (zh) 一种基于n-(3-羟基吡啶-2-羰基)甘氨酸的抗肿瘤药物增敏剂及其应用
CN108888623A (zh) 酪氨酸蛋白激酶jak2抑制剂bx795的应用
JP2006124296A (ja) ヘリコバクター・ピロリ菌感染症治療のための医薬組成物
US7956079B2 (en) Antihepatitis C virus agent and anti-HIV agent
KR101703827B1 (ko) 신규한 커큐민 유도체 및 이의 용도
CN114478464B (zh) 一种炎症小体选择性抑制剂及其合成方法和应用
CN110218174B (zh) 一种化合物及其制备方法和应用
JP2005162634A (ja) Ｄｎａ合成酵素阻害剤

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20130305